Last 7 days
0.1%
Last 30 days
1.6%
Last 90 days
7.3%
Trailing 12 Months
-2.6%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 1.6B | 1.7B | 1.8B | 0 |
2022 | 1.2B | 1.3B | 1.4B | 1.5B |
2021 | 1.0B | 1.0B | 1.1B | 1.1B |
2020 | 886.8M | 1.0B | 1.0B | 1.0B |
2019 | 518.6M | 605.1M | 675.5M | 788.1M |
2018 | 232.7M | 323.3M | 414.3M | 451.2M |
2017 | 51.7M | 88.3M | 125.0M | 161.6M |
2016 | 15.0M | 15.0M | 15.0M | 15.0M |
2015 | 0 | 0 | 0 | 19.8M |
2014 | 0 | 0 | 0 | 0 |
2013 | 40.6M | 28.0M | 15.5M | 2.9M |
2012 | 76.2M | 74.6M | 42.3M | 53.1M |
2011 | 45.3M | 52.8M | 80.0M | 77.4M |
2010 | 10.6M | 18.2M | 25.9M | 33.5M |
2009 | 0 | 0 | 0 | 3.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 01, 2023 | lyons gary a | acquired | 64,900 | 12.98 | 5,000 | - |
Dec 01, 2023 | lyons gary a | sold | -583,837 | 116 | -5,000 | - |
Nov 29, 2023 | onyia jude | sold | -264,733 | 113 | -2,331 | chief scientific officer |
Nov 27, 2023 | lippoldt darin | sold | -1,225,910 | 112 | -10,919 | chief legal officer |
Nov 16, 2023 | sherwin stephen a | gifted | - | - | -2,750 | - |
Oct 02, 2023 | boyer david w. | sold | -161,921 | 112 | -1,437 | chief corp. affairs officer |
Sep 12, 2023 | lyons gary a | acquired | 64,900 | 12.98 | 5,000 | - |
Sep 12, 2023 | lyons gary a | sold | -575,120 | 115 | -5,000 | - |
Sep 01, 2023 | lyons gary a | sold | -550,316 | 110 | -5,000 | - |
Sep 01, 2023 | cooke julie | sold | -91,406 | 110 | -824 | chief human resources officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 07, 2023 | Hudson Bay Capital Management LP | added | 29.03 | 3,941,750 | 11,250,000 | 0.04% |
Dec 06, 2023 | CITIGROUP INC | reduced | -9.22 | 1,637,790 | 21,357,900 | 0.02% |
Nov 27, 2023 | TRUST CO OF VERMONT | sold off | -100 | -9,996 | - | -% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | reduced | -22.43 | -2,514,960 | 31,196,300 | 0.02% |
Nov 22, 2023 | Aurora Investment Counsel | reduced | -0.92 | 231,896 | 1,505,700 | 1.00% |
Nov 22, 2023 | KBC Group NV | unchanged | - | - | 2,811,000 | 0.01% |
Nov 22, 2023 | Polar Capital Holdings Plc | reduced | -13.33 | 1,200,000 | 36,562,500 | 0.27% |
Nov 21, 2023 | Walleye Capital LLC | new | - | 3,455,210 | 3,455,210 | 0.01% |
Nov 21, 2023 | COMERICA BANK | new | - | 7,418 | 7,418 | -% |
Nov 21, 2023 | COMERICA BANK | added | 756 | 17,431,700 | 17,491,700 | 0.09% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | janus henderson group plc | 2.5% | 2,415,638 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.72% | 9,340,295 | SC 13G/A | |
Jan 23, 2023 | blackrock inc. | 13.1% | 12,627,403 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 4.5% | 4,359,645 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.26% | 8,787,991 | SC 13G/A | |
Feb 10, 2022 | janus henderson group plc | 7.8% | 7,445,839 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 12.1% | 11,476,545 | SC 13G/A | |
Jan 26, 2022 | blackrock inc. | 12.1% | 11,476,545 | SC 13G/A | |
Aug 10, 2021 | fmr llc | - | 0 | SC 13G/A | |
Apr 12, 2021 | blackrock inc. | 11.7% | 10,989,646 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 08, 2023 | 4 | Insider Trading | |
Dec 08, 2023 | 4 | Insider Trading | |
Dec 06, 2023 | 144 | Notice of Insider Sale Intent | |
Dec 06, 2023 | 144 | Notice of Insider Sale Intent | |
Dec 05, 2023 | 4 | Insider Trading | |
Dec 01, 2023 | 144 | Notice of Insider Sale Intent | |
Dec 01, 2023 | 4 | Insider Trading | |
Nov 29, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 29, 2023 | 4 | Insider Trading | |
Nov 27, 2023 | 144 | Notice of Insider Sale Intent |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 389.5B | 102.8B | 2.69% | -12.25% | 11.25 | 3.79 | 11.47% | 80.74% |
MRK | 272.8B | 59.3B | -0.63% | -5.14% | 17.88 | 4.63 | 0.58% | -69.80% |
PFE | 162.5B | 68.5B | -6.62% | -44.42% | 15.5 | 2.37 | -31.38% | -64.79% |
AMGN | 144.0B | 26.8B | -1.52% | -4.93% | 19.03 | 5.37 | 1.91% | 10.69% |
GILD | 98.5B | 27.4B | 1.44% | -10.10% | 16.77 | 3.6 | 0.94% | 76.21% |
MID-CAP | ||||||||
TEVA | 11.0B | 15.3B | 7.32% | 18.03% | -4.98 | 0.72 | 0.87% | -71.24% |
ALKS | 4.3B | 1.6B | 4.36% | 1.49% | 20.08 | 2.71 | 40.56% | 266.27% |
PRGO | 4.0B | 4.7B | 2.10% | -7.72% | -978.12 | 0.86 | 5.74% | 96.18% |
AMPH | 2.7B | 601.3M | 24.99% | 94.42% | 20.1 | 4.52 | 24.02% | 75.17% |
BHC | 2.7B | 8.5B | 1.81% | -4.07% | -2.77 | 0.31 | 5.11% | -479.13% |
SMALL-CAP | ||||||||
TLRY | 1.4B | 650.9M | 10.34% | -28.86% | -0.96 | 2.13 | 6.08% | -185.21% |
TXMD | 22.1M | - | -5.00% | -65.05% | 0.32 | 0.55 | -19.54% | 888.31% |
ACOR | 15.2M | 111.1M | 27.41% | 2089.90% | -0.96 | 0.14 | -10.43% | 84.90% |
ACRX | 12.5M | - | 39.62% | -61.05% | -0.59 | 0.13 | 287.27% | -145.15% |
AGRX | 5.2M | 20.0M | 16.16% | 1110.53% | -0.38 | 0.26 | 137.71% | 66.04% |
Income Statement (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 10.2% | 499 | 453 | 420 | 412 | 388 | 378 | 311 | 312 | 296 | 289 | 237 | 248 | 259 | 302 | 237 | 244 | 222 | 184 | 138 | 131 | 152 |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 | 2.00 | - | 1.00 | 2.00 | 2.00 |
Costs and Expenses | -5.7% | 358 | 379 | 535 | 309 | 300 | 324 | 308 | 348 | 252 | 226 | 205 | 176 | 303 | 226 | 178 | - | 132 | 149 | - | - | - |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 176 | 303 | 226 | 178 | 195 | 132 | 149 | 239 | 110 | 97.00 |
S&GA Expenses | -7.9% | 204 | 222 | 243 | 183 | 186 | 183 | 201 | 157 | 155 | 143 | 129 | 107 | 113 | 97.00 | 118 | 101 | 85.00 | 81.00 | 88.00 | 69.00 | 60.00 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | 73.00 | - | - | - | 58.00 | - | - | 62.00 | 38.00 | 39.00 | 35.00 |
EBITDA Margin | 0.5% | 0.15* | 0.15* | 0.07* | 0.16* | 0.08* | 0.04* | 0.11* | 0.12* | 0.18* | 0.10* | 0.13* | 0.14* | 0.14* | 0.26* | 0.26* | - | - | - | - | - | - |
Interest Expenses | -15.4% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 3.00 | 7.00 | 7.00 | 6.00 | 6.00 | 8.00 | 9.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
Income Taxes | 24.5% | 33.00 | 26.00 | -26.70 | 29.00 | 29.00 | -6.40 | 8.00 | -6.50 | 8.00 | 15.00 | -4.90 | -306 | 1.00 | 4.00 | 2.00 | 5.00 | 5.00 | 1.00 | -0.50 | - | - |
Earnings Before Taxes | -4.9% | 116 | 122 | -103 | 118 | 98.00 | -23.30 | 21.00 | -13.80 | 31.00 | 58.00 | 27.00 | 42.00 | -57.10 | 83.00 | 39.00 | 39.00 | 58.00 | 52.00 | -102 | 19.00 | 51.00 |
EBT Margin | 0.9% | 0.14* | 0.14* | 0.06* | 0.14* | 0.06* | 0.01* | 0.08* | 0.09* | 0.15* | 0.07* | 0.09* | 0.10* | 0.10* | 0.22* | 0.21* | - | - | - | - | - | - |
Net Income | -13.0% | 83.00 | 96.00 | -76.60 | 89.00 | 69.00 | -16.90 | 14.00 | -7.30 | 23.00 | 42.00 | 32.00 | 348 | -57.60 | 80.00 | 37.00 | 34.00 | 54.00 | 51.00 | -102 | 18.00 | 51.00 |
Net Income Margin | 1.5% | 0.11* | 0.11* | 0.04* | 0.10* | 0.04* | 0.01* | 0.06* | 0.08* | 0.42* | 0.35* | 0.38* | 0.39* | 0.09* | 0.20* | 0.20* | - | - | - | - | - | - |
Free Cashflow | 18.3% | 204 | 173 | -133 | 141 | 101 | 129 | -48.10 | -4.70 | 56.00 | 99.00 | 83.00 | 84.00 | -17.90 | 117 | 34.00 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 9.0% | 2,848 | 2,613 | 2,360 | 2,369 | 2,143 | 2,006 | 2,145 | 2,073 | 2,017 | 1,956 | 1,846 | 1,735 | 1,503 | 1,516 | 1,362 | 1,306 | 1,180 | 1,067 | 958 | 993 | 934 |
Current Assets | 10.2% | 1,650 | 1,497 | 1,433 | 1,454 | 1,206 | 1,019 | 1,018 | 973 | 1,006 | 1,110 | 1,085 | 1,016 | 1,157 | 1,146 | 968 | 831 | 819 | 749 | 633 | 738 | 714 |
Cash Equivalents | 83.3% | 294 | 160 | 104 | 263 | 212 | 163 | 270 | 344 | 311 | 368 | 353 | 190 | 425 | 415 | 187 | 116 | 172 | 147 | 78.00 | 147 | 201 |
Inventory | -9.1% | 29.00 | 32.00 | 33.00 | 35.00 | 37.00 | 29.00 | 29.00 | 31.00 | 26.00 | 28.00 | 30.00 | 28.00 | 21.00 | 22.00 | 21.00 | 17.00 | 11.00 | 12.00 | 13.00 | 11.00 | 6.00 |
Net PPE | 4.9% | 69.00 | 66.00 | 63.00 | 59.00 | 61.00 | 67.00 | 64.00 | 59.00 | 51.00 | 50.00 | 45.00 | 45.00 | 43.00 | 45.00 | 42.00 | 42.00 | 40.00 | 40.00 | 37.00 | 34.00 | 29.00 |
Liabilities | 11.3% | 846 | 760 | 675 | 661 | 599 | 582 | 753 | 699 | 671 | 677 | 641 | 609 | 698 | 684 | 662 | 669 | 605 | 583 | 548 | 512 | 486 |
Current Liabilities | 18.7% | 692 | 583 | 374 | 538 | 485 | 286 | 254 | 246 | 226 | 213 | 190 | 187 | 611 | 573 | 140 | 565 | 116 | 101 | 72.00 | 88.00 | 456 |
Shareholder's Equity | 8.0% | 2,002 | 1,853 | 1,685 | 1,708 | 1,545 | 1,423 | 1,391 | 1,374 | 1,346 | 1,279 | 1,206 | 1,126 | 804 | 831 | 700 | 637 | 575 | 484 | 409 | 481 | 448 |
Retained Earnings | 21.4% | -304 | -387 | -483 | -406 | -495 | -564 | -547 | -635 | -628 | -651 | -693 | -725 | -1,073 | -1,015 | -1,095 | -1,132 | -1,166 | -1,220 | -1,271 | -1,177 | -1,195 |
Additional Paid-In Capital | 3.0% | 2,309 | 2,242 | 2,171 | 2,122 | 2,054 | 2,000 | 1,948 | 2,011 | 1,974 | 1,929 | 1,898 | 1,850 | 1,874 | 1,842 | 1,797 | 1,768 | 1,740 | 1,703 | 1,681 | 1,660 | 1,645 |
Shares Outstanding | 0.6% | 98.00 | 98.00 | 98.00 | 97.00 | 96.00 | 96.00 | 95.00 | 95.00 | 95.00 | 95.00 | 94.00 | 94.00 | 93.00 | 93.00 | 93.00 | 92.00 | 92.00 | 91.00 | 91.00 | 91.00 | 91.00 |
Cashflow (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 18.0% | 212,000 | 179,600 | -125,200 | 143,000 | 98,800 | 138,100 | -40,500 | 4,200 | 61,800 | 103,200 | 87,300 | 94,500 | -20,400 | 118,900 | 35,500 | 97,500 | 97,800 | 64,200 | -112,500 | 50,490 | 68,917 |
Share Based Compensation | -30.2% | 47,800 | 68,500 | 39,900 | 43,500 | 43,100 | 49,500 | 37,000 | 35,600 | 37,100 | 28,600 | 32,900 | 21,000 | 26,700 | 29,500 | 22,800 | 21,300 | 20,300 | 17,900 | 15,800 | 13,300 | 13,070 |
Cashflow From Investing | 22.7% | -97,300 | -125,900 | -42,100 | -115,600 | -61,300 | 31,400 | -31,600 | 23,700 | -126,200 | -90,800 | 63,100 | -147,700 | 25,200 | 93,400 | 33,200 | -166,200 | -85,600 | -300 | 41,000 | -106,241 | -45,095 |
Cashflow From Financing | 548.3% | 18,800 | 2,900 | 8,200 | 24,600 | 11,400 | -276,400 | 6,100 | 1,800 | 7,500 | 3,000 | 15,100 | -185,000 | 5,400 | 15,800 | 6,000 | 12,400 | 13,100 | 4,300 | 2,600 | 1,752 | 5,490 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenues: | ||||
Revenues | $ 498.8 | $ 387.9 | $ 1,371.9 | $ 1,076.7 |
Operating expenses: | ||||
Cost of revenues | 11.2 | 6.1 | 31.2 | 15.5 |
Research and development | 142.2 | 107.7 | 427.5 | 345.8 |
Acquired in-process research and development | 0.0 | 0.0 | 143.9 | 0.0 |
Selling, general and administrative | 204.2 | 186.3 | 668.7 | 569.8 |
Total operating expenses | 357.6 | 300.1 | 1,271.3 | 931.1 |
Operating income | 141.2 | 87.8 | 100.6 | 145.6 |
Other income (expense): | ||||
Interest expense | (1.1) | (1.2) | (3.5) | (6.0) |
Unrealized (loss) gain on equity security investments | (40.1) | 11.1 | (0.6) | 23.6 |
Loss on extinguishment of convertible senior notes | 0.0 | 0.0 | 0.0 | (70.0) |
Investment income and other, net | 15.6 | 0.2 | 37.4 | 2.8 |
Total other (expense) income, net | (25.6) | 10.1 | 33.3 | (49.6) |
Income before provision for income taxes | 115.6 | 97.9 | 133.9 | 96.0 |
Provision for income taxes | 32.5 | 29.4 | 31.9 | 30.5 |
Net income | 83.1 | 68.5 | 102.0 | 65.5 |
Foreign currency translation adjustments, net of tax | (1.4) | 0.0 | 0.7 | 0.0 |
Unrealized gain (loss) on debt securities available-for-sale, net of tax | 0.8 | (1.8) | 5.5 | (12.3) |
Comprehensive income | $ 82.5 | $ 66.7 | $ 108.2 | $ 53.2 |
Earnings per share: | ||||
Basic (in USD per share) | $ 0.85 | $ 0.72 | $ 1.05 | $ 0.69 |
Diluted (in USD per share) | $ 0.82 | $ 0.69 | $ 1.01 | $ 0.67 |
Weighted-average shares outstanding: | ||||
Basic (in shares) | 97.9 | 95.8 | 97.5 | 95.6 |
Diluted (in shares) | 101.1 | 99.0 | 100.6 | 98.3 |
Net product sales | ||||
Revenues: | ||||
Revenues | $ 491.8 | $ 379.3 | $ 1,353.4 | $ 1,036.3 |
Collaboration revenues | ||||
Revenues: | ||||
Revenues | $ 7.0 | $ 8.6 | $ 18.5 | $ 40.4 |
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 293.7 | $ 262.9 |
Debt securities available-for-sale | 801.4 | 726.4 |
Accounts receivable | 417.8 | 350.0 |
Inventories | 28.8 | 35.1 |
Other current assets | 108.2 | 79.1 |
Total current assets | 1,649.9 | 1,453.5 |
Deferred tax assets | 383.2 | 305.9 |
Debt securities available-for-sale | 454.7 | 299.4 |
Right-of-use assets | 80.8 | 87.0 |
Equity security investments | 132.8 | 102.1 |
Property and equipment, net | 68.8 | 58.6 |
Intangible assets, net | 34.9 | 37.2 |
Other assets | 43.1 | 25.0 |
Total assets | 2,848.2 | 2,368.7 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 503.0 | 347.6 |
Convertible senior notes | 169.9 | 169.4 |
Other current liabilities | 18.7 | 20.7 |
Total current liabilities | 691.6 | 537.7 |
Noncurrent operating lease liabilities | 85.9 | 93.5 |
Other long-term liabilities | 68.6 | 29.7 |
Total liabilities | 846.1 | 660.9 |
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; 5.0 million shares authorized; no shares issued and outstanding | 0.0 | 0.0 |
Common stock, $0.001 par value; 220.0 million shares authorized; 98.2 million and 96.5 million shares issued and outstanding, respectively | 0.1 | 0.1 |
Additional paid-in capital | 2,308.5 | 2,122.4 |
Accumulated other comprehensive loss | (1.7) | (7.9) |
Accumulated deficit | (304.8) | (406.8) |
Total stockholders’ equity | 2,002.1 | 1,707.8 |
Total liabilities and stockholders’ equity | $ 2,848.2 | $ 2,368.7 |
CEO | Dr. Kevin C. Gorman Ph.D. |
---|---|
WEBSITE | www.neurocrine.com |
EMPLOYEES | 1350 |